Darin Lippoldt, Chief Legal Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 7,004 shares at $150.00 ($1.1M) on 2024-07-16, disclosed to the SEC on 2024-07-18.
Scheduled sale ($1.1M) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NBIX | SELL | 2025-12-10 | $1.4M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $510K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $215K | — | Filing → |